These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24240582)

  • 1. A systematic review of hypermethylation of p16 gene in esophageal cancer.
    Xu R; Wang F; Wu L; Wang J; Lu C
    Cancer Biomark; 2013; 13(4):215-26. PubMed ID: 24240582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis demonstrates no association between p16
    Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
    Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A methylation in esophageal cancer: a meta-analysis.
    Zhou C; Li J; Li Q
    Oncotarget; 2017 Jul; 8(30):50071-50083. PubMed ID: 28637022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of CDKN2A methylation to find its role in prostate cancer development and progression, and also to find the effect of CDKN2A expression on disease-free survival (PRISMA).
    Cao Z; Wei L; Zhu W; Yao X
    Medicine (Baltimore); 2018 Mar; 97(12):e0182. PubMed ID: 29561434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16 hypermethylation: a biomarker for increased esophageal cancer susceptibility in high incidence region of North East India.
    Das M; Saikia BJ; Sharma SK; Sekhon GS; Mahanta J; Phukan RK
    Tumour Biol; 2015 Mar; 36(3):1627-42. PubMed ID: 25361631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma.
    Hibi K; Taguchi M; Nakayama H; Takase T; Kasai Y; Ito K; Akiyama S; Nakao A
    Clin Cancer Res; 2001 Oct; 7(10):3135-8. PubMed ID: 11595706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
    Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
    Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ analysis of p16/INK4 promoter hypermethylation in esophageal carcinoma and gastric carcinoma.
    Zhang F; Wang L; Wu PP; Yan ZW; Zheng L; Yu YY; Jiang XC
    Chin J Dig Dis; 2004; 5(4):149-55. PubMed ID: 15612883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.
    Hu ZY; Tang LD; Zhou Q; Xiao L; Cao Y
    Tumour Biol; 2015 Mar; 36(3):1487-91. PubMed ID: 25596080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
    Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
    Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.
    Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H
    Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation patterns of P16, DAPK and MGMT in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Don KR; Ramani P; Ramshankar V; Sherlin HJ; Premkumar P; Natesan A
    Indian J Dent Res; 2014; 25(6):797-805. PubMed ID: 25728117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma.
    Wang J; Sasco AJ; Fu C; Xue H; Guo G; Hua Z; Zhou Q; Jiang Q; Xu B
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):118-25. PubMed ID: 18199718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma.
    Abbaszadegan MR; Raziee HR; Ghafarzadegan K; Shakeri MT; Afsharnezhad S; Ghavamnasiry MR
    Int J Gastrointest Cancer; 2005; 36(1):47-54. PubMed ID: 16227635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of serum p16 gene promoter methylation for diagnosis of nonsmall cell lung cancer.
    Yan R; Chi L; Zheng X; Sun R; You J; Ye X
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e116-8. PubMed ID: 26728668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of risk factors obesity and occupational airborne exposures with CDKN2A/p16 aberrant DNA methylation in esophageal cancer patients.
    Mohammad Ganji S; Miotto E; Callegari E; Sayehmiri K; Fereidooni F; Yazdanbod M; Rastgar-Jazii F; Negrini M
    Dis Esophagus; 2010 Sep; 23(7):597-602. PubMed ID: 20459442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer.
    Kondo K; Takahashi Y; Hirose Y; Nagao T; Tsuyuguchi M; Hashimoto M; Ochiai A; Monden Y; Tangoku A
    Lung Cancer; 2006 Sep; 53(3):295-302. PubMed ID: 16828922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.